Inscripta Appoints Ron McGrath as Chief Financial Officer

Boulder, CO – Inscripta, developer of the first scalable platform for benchtop Digital Genome Engineering, today announced the appointment of Ron McGrath as Chief Financial Officer. Mr. McGrath has held leadership and financial roles for more than 25 years in the biotechnology and information technology industries, most recently at Illumina, the leader in DNA sequencing [...]

REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification

REPROCELL USA has achieved ISO9001:2015 accreditation for quality management utilizing the standard operating protocols established over many years by REPROCELL, Japan, BioServe, Stemgent and Biopta. REPROCELL USA will provide quality bio-repository material, stem cell products and offer services related to pre-clinical genomics, stem cell and drug discovery under this certification.  BELTSVILLE, MD. By achieving certification [...]

Ohio Lumex Appointed Exclusive Distributor of G.A.S. Products in United States and Canada

CLEVELAND, OH – Ohio Lumex, a global leader in environmental and process monitoring, has been awarded exclusive distribution rights of G.A.S. GC-IMS products in the U.S. and Canada. G.A.S., based in Dortmund, Germany, develops custom instruments that detect and quantify hazardous or unwanted compounds at low ppb-level in air or gases. They use a unique two-stage separation technique [...]

FluroTech Appoints Duane Sniezek as Director of Science and Technology

CALGARY, Alberta -- FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce the appointment of Duane Sniezek as the full-time Director of Science and Technology. Duane will be hands-on in leading enhancements of the CompleTest™. “The continuing commercialization of the CompleTest™ is our number one priority,” stated Danny Dalla-Longa. “Duane has demonstrated his ability to bring new [...]

Australia’s First Commercial MGISEQ-2000 Genetic Sequencer Now in Operation

MELBOURNE, Australia -- MGI, a division of global genomics leader BGI Group, announced that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. Monash University's Micromon Genomics, a next-generation sequencing facility located in the university's Biomedical precinct at the Clayton campus in Melbourne, provides sequencing services to Australian researchers, including DNA, RNA, single cell and [...]

Stellenbosch University study the morphology and mechanical properties of snake fangs using the Deben CT500.

In 2017 Stellenbosch University, South Africa undertook an experimental campaign which focused on analysing venomous snake fangs. The motivation behind the campaign was to understand in detail the internal and external morphology and mechanical properties of snake fangs. The study focused on comparing the maximum Von Mises stress values when a load was applied to [...]

Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Food and Drug Administration Opioid Inspection Program

The Rigaku Progeny ResQ 1064 nm handheld Raman analyzer will be considered as a capability to provide on-site narcotics and pharmaceutical analysis at import facilities. Wilmington, MA (April 29, 2019) – Rigaku Analytical Devices, a U.S.-based, leading pioneer of handheld and portable spectroscopic analyzers, is pleased to announce the Rigaku Progeny ResQ 1064 nm handheld Raman analyzer will be [...]

Kewaunee Scientific Announces the Appointment of a New Vice President of Finance & CFO

STATESVILLE, N.C. -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Donald T. Gardner III has joined the Company as Vice President of Finance and Chief Financial Officer. In addition, Mr. Gardner has been elected by the Board of Directors to the positions of Secretary and Treasurer of the Company. Thomas D. Hull III, who had continued to serve as Kewaunee's [...]

New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for bisulfite-free methylation analysis

This new enzyme-based system allows scientists to accurately and sensitively assess DNA methylation without bisulfite treatment, for epigenetics research. IPSWICH, MA — New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis. Bisulfite treatment has long been the gold standard for methylome analysis, specifically [...]

Company Name Change Announcement

Access IBO on Knowledge Center